H.R. 6980 · 117th Congress · House

To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.

Active· Referred to the Subcommittee on Health.
Introduced
Mar 8, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.

Action Timeline

4
  1. MAR 09, 2022•Committee

    Referred to the Subcommittee on Health.

  2. MAR 08, 2022•IntroReferral

    Introduced in House

  3. MAR 08, 2022•IntroReferral

    Introduced in House

  4. MAR 08, 2022•IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Mar 9, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Mar 8, 2022

Active